Prescription drug · ANDA
Lamotrigine NDC 68084-318
Lamotrigine 25 mg/1 · Tablet · Oral · American Health Packaging
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68084-318-01 | 6808403180168084031801 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-318-01) / 1 TABLET in 1 BLISTER PACK (68084-318-11)Marketed from Jul 7, 2009 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lamotrigine
- Generic name (nonproprietary)
- lamotrigine
- Active ingredients
- Lamotrigine — 25 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- American Health PackagingNDC labeler code 68084
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077633
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)Dihydrofolate Reductase Inhibitors (Mechanism)Organic Cation Transporter 2 Inhibitors (Mechanism)
- Identifiers
- Product ID 68084-318_57d4fcd2-5f9e-1832-e063-6394a90a63f2SPL ID 57d4fcd2-5f9e-1832-e063-6394a90a63f2SPL set ID 35aa48a2-2ce6-4a6e-bf5a-1bc6111d1234RxCUI 198427, 282401UNII U3H27498KS
- Pharmacologic class
- Anti-epileptic Agent; Mood Stabilizer
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468084031801followed by a unit qualifier and the quantityPackage 68084-0318-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Lamotrigine is indicated for: Epilepsy — adjunctive therapy in patients aged 2 years and older: partial-onset seizures. primary generalized tonic-clonic (PGTC) seizures. generalized seizures of Lennox-Gastaut syndrome. (1.1) Epilepsy—monotherapy in patients aged 16 years and older: Conversion to monotherapy in patients with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug. (1.1) Bipolar disorder: Maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes in patients treated for acute mood episodes with standard therapy. (1.2) Limitations of Use: Treatment…
Excerpt only. Read the full label for complete information.
About NDC 68084-318
- What is NDC 68084-318?
- 68084-318 is the product NDC for Lamotrigine, Lamotrigine 25 mg/1 tablet, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lamotrigine.
- What is the active ingredient?
- Lamotrigine.
- Who is the labeler?
- American Health Packaging, NDC labeler code 68084. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lamotrigine?
- 262 other product NDCs are listed under this name. See all Lamotrigine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lamotrigine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lamotrigine | Lamotrigine 50 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-4702 | 70518-4702-00 |
| Lamotrigine | Lamotrigine 25 mg/1 | TabletOral | Coupler LLC | 67046-0358 | 67046-0358-03 |
| Lamotrigine | Lamotrigine 150 mg/1 | TabletOral | Coupler LLC | 67046-0749 | 67046-0749-03 |
| Lamotrigine | Lamotrigine 100 mg/1 | TabletOral | Coupler LLC | 67046-0359 | 67046-0359-03 |
| lamotriginelamotrigine extended-release | Lamotrigine 200 mg/1 | Tablet, Film coated, Extended releaseOral | REMEDYREPACK INC. | 70518-4638 | 70518-4638-00 |
| Lamotrigine | Lamotrigine 25 mg/1 | Tablet, Orally disintegratingOral | Alembic Pharmaceuticals Inc. | 62332-770 | 62332-0770-1562332-0770-30 |
| Lamotrigine | Lamotrigine 50 mg/1 | Tablet, Orally disintegratingOral | Alembic Pharmaceuticals Inc. | 62332-771 | 62332-0771-1562332-0771-30 |
| Lamotrigine | Lamotrigine 100 mg/1 | Tablet, Orally disintegratingOral | Alembic Pharmaceuticals Inc. | 62332-772 | 62332-0772-1062332-0772-30 |
| Lamotrigine | Lamotrigine 200 mg/1 | Tablet, Orally disintegratingOral | Alembic Pharmaceuticals Inc. | 62332-773 | 62332-0773-1062332-0773-30 |
| Lamotrigine | Lamotrigine 25 mg/1 | Tablet, Orally disintegratingOral | Alembic Pharmaceuticals Limited | 46708-770 | 46708-0770-1546708-0770-30 |
Other NDCs under ANDA 077633
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lamotrigine | Lamotrigine 150 mg/1 | TabletOral | American Health Packaging | 60687-693 |
| Lamotrigine | Lamotrigine 200 mg/1 | TabletOral | American Health Packaging | 60687-704 |
| Lamotrigine | Lamotrigine 25 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-006 |
| Lamotrigine | Lamotrigine 50 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-007 |
| Lamotrigine | Lamotrigine 100 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-2563 |
| Lamotrigine | Lamotrigine 100 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-008 |
| Lamotrigine | Lamotrigine 150 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-009 |
| Lamotrigine | Lamotrigine 200 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-010 |
| Lamotrigine | Lamotrigine 250 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-011 |
| Lamotrigine | Lamotrigine 150 mg/1 | TabletOral | Quallent Pharmaceuticals Health LLC | 82009-133 |
| Lamotrigine | Lamotrigine 25 mg/1 | TabletOral | Quallent Pharmaceuticals Health LLC | 82009-131 |
| Lamotrigine | Lamotrigine 100 mg/1 | TabletOral | Quallent Pharmaceuticals Health LLC | 82009-132 |
| Lamotrigine | Lamotrigine 200 mg/1 | TabletOral | Quallent Pharmaceuticals Health LLC | 82009-134 |
| Lamotrigine | Lamotrigine 100 mg/1 | TabletOral | Northwind Health Company, LLC | 82868-005 |
| Lamotrigine | Lamotrigine 200 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1919 |
| Lamotrigine | Lamotrigine 100 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-3514 |
| Lamotrigine | Lamotrigine 100 mg/1 | TabletOral | Cardinal Health 107, LLC | 55154-2065 |
| Lamotrigine | Lamotrigine 100 mg/1 | TabletOral | A-S Medication Solutions | 50090-5827 |
| Lamotrigine | Lamotrigine 150 mg/1 | TabletOral | A-S Medication Solutions | 50090-5850 |
| Lamotrigine | Lamotrigine 200 mg/1 | TabletOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8267 |
Showing 20 of 39.